Colorado Pharmacies Concerned Over PDAB UPL Reimbursements

Colorado pharmacies are concerned they may not receive adequate reimbursement after the state’s prescription drug affordability board (PDAB) determines an upper payment limit (UPL) for drugs it deems unaffordable, and a pharmacy group says it has unanswered questions about the process. Eyes are on Colorado’s PDAB as it is the first state in the nation to consider setting a UPL on a drug. The board is currently considering whether to set an upper payment limit on Amgen’s drug Enbrel, used...